So much societal damage for a virus with an infection mortality rate (IFR) roughly similar (or likely lower once all infection data are collected) to seasonal influenza. Stanford’s John P.A. Ioannidis identified 36 studies (43 estimates) along with an additional 7 preliminary national estimates (50 pieces of data) and concluded that among people <70 years old across the world, infection fatality rates ranged from 0.00% to 0.57% with a median of 0.05% across the different global locations (with a corrected median of 0.04%). The rate of survival for those under 70 years is 99.5%. Moreover, the IFR has been shown to be near zero for children and young adults. While anyone is at risk of being infected, “there is more than a thousand-fold difference in the risk of death between the old and the young.”
.
⬇️
The infection fatality rate of COVID-19 inferred from seroprevalence data
WHO DELETED THE STUDY FROM ITS WEBSITE
John P.A. Ioannidis
BROWNSTONE SEPTEMBER 2021
Twenty Steps to End the Madness
https://brownstone.org/articles/twenty-steps-to-end-the-madness/
ARCHIVED ⬇️
https://archive.md/2021.10.04-120547/https://brownstone.org/articles/twenty-steps-to-end-the-madness/
So much societal damage for a virus with an infection mortality rate (IFR) roughly similar (or likely lower once all infection data are collected) to seasonal influenza. Stanford’s John P.A. Ioannidis identified 36 studies (43 estimates) along with an additional 7 preliminary national estimates (50 pieces of data) and concluded that among people <70 years old across the world, infection fatality rates ranged from 0.00% to 0.57% with a median of 0.05% across the different global locations (with a corrected median of 0.04%). The rate of survival for those under 70 years is 99.5%. Moreover, the IFR has been shown to be near zero for children and young adults. While anyone is at risk of being infected, “there is more than a thousand-fold difference in the risk of death between the old and the young.”
.
⬇️
The infection fatality rate of COVID-19 inferred from seroprevalence data
https://www.medrxiv.org/content/10.1101/2020.05.13.20101253v3
PDF ⬇️
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947934/pdf/BLT.20.265892.pdf/